A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance
Oseltamivir, a neuraminidase (NA) inhibitor, is currently the most widely used antiviral drug for influenza worldwide. The emergence of primary oseltamivir-resistant mutations i...